APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Osimertinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025188 pages

Choose your research edition.

Industry ResearchOsimertinib Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Osimertinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Osimertinib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Osimertinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osimertinib include Beacon Pharma, Drug International, Everest Pharmaceuticals, Incepta Pharmaceuticals Limited and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Osimertinib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Osimertinib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Osimertinib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Osimertinib market size, projected growth trends, production technologies, key applications, and end-use industries.

Osimertinib Segment by Company

Beacon Pharma

Drug International

Everest Pharmaceuticals

Incepta Pharmaceuticals Limited

AstraZeneca

Osimertinib Segment by Type

80mg*30 Tablets

80mg*10 Tablets

40mg*30 Tablets

40mg*10 Tablets

Osimertinib Segment by Application

Locally Advanced NSCLC

Metastatic NSCLC

Others

Osimertinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Osimertinib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Osimertinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Osimertinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Osimertinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Osimertinib Industry Trends Table 2. Osimertinib Industry Drivers Table 3. Osimertinib Industry Opportunities and Challenges Table 4. Osimertinib Industry Restraints Table 5. Global Osimertinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Osimertinib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Osimertinib Sales by Manufacturers (k pcs) & (2021-2026) Table 8. Global Osimertinib Sales Market Share by Manufacturers Table 9. Global Osimertinib Average Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 10. Global Osimertinib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Osimertinib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Osimertinib Manufacturers, Product Type & Application Table 13. Global Osimertinib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Osimertinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 80mg*30 Tablets Table 17. Major Manufacturers of 80mg*10 Tablets Table 18. Major Manufacturers of 40mg*30 Tablets Table 19. Major Manufacturers of 40mg*10 Tablets Table 20. Global Osimertinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 21. Global Osimertinib Sales by Type (2021-2026) & (k pcs) Table 22. Global Osimertinib Sales by Type (2027-2032) & (k pcs) Table 23. Global Osimertinib Sales Market Share by Type (2021-2026) Table 24. Global Osimertinib Sales Market Share by Type (2027-2032) Table 25. Global Osimertinib Revenue by Type 2021 VS 2025 VS 2032 (k pcs) Table 26. Global Osimertinib Revenue by Type (2021-2026) & (k pcs) Table 27. Global Osimertinib Revenue by Type (2027-2032) & (k pcs) Table 28. Global Osimertinib Revenue Market Share by Type (2021-2026) Table 29. Global Osimertinib Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Locally Advanced NSCLC Table 31. Major Manufacturers of Metastatic NSCLC Table 32. Major Manufacturers of Others Table 33. Global Osimertinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Osimertinib Sales by Application (2021-2026) & (k pcs) Table 35. Global Osimertinib Sales by Application (2027-2032) & (k pcs) Table 36. Global Osimertinib Sales Market Share by Application (2021-2026) Table 37. Global Osimertinib Sales Market Share by Application (2027-2032) Table 38. Global Osimertinib Revenue by Application 2021 VS 2025 VS 2032 (k pcs) Table 39. Global Osimertinib Revenue by Application (2021-2026) & (k pcs) Table 40. Global Osimertinib Revenue by Application (2027-2032) & (k pcs) Table 41. Global Osimertinib Revenue Market Share by Application (2021-2026) Table 42. Global Osimertinib Revenue Market Share by Application (2027-2032) Table 43. Global Osimertinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Osimertinib Sales by Region (2021-2026) & (k pcs) Table 45. Global Osimertinib Sales Market Share by Region (2021-2026) Table 46. Global Osimertinib Sales Forecasted by Region (2027-2032) & (k pcs) Table 47. Global Osimertinib Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 49. North America Osimertinib Sales by Country (2021-2026) & (k pcs) Table 50. North America Osimertinib Sales by Country (2027-2032) & (k pcs) Table 51. Europe Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 52. Europe Osimertinib Sales by Country (2021-2026) & (k pcs) Table 53. Europe Osimertinib Sales by Country (2027-2032) & (k pcs) Table 54. Asia Pacific Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 55. Asia Pacific Osimertinib Sales by Country (2021-2026) & (k pcs) Table 56. Asia Pacific Osimertinib Sales by Country (2027-2032) & (k pcs) Table 57. South America, Middle East and Africa Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 58. South America, Middle East and Africa Osimertinib Sales by Country (2021-2026) & (k pcs) Table 59. South America, Middle East and Africa Osimertinib Sales by Country (2027-2032) & (k pcs) Table 60. Global Osimertinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Osimertinib Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Osimertinib Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Osimertinib Revenue Market Share by Region (2021-2026) Table 64. Global Osimertinib Revenue Market Share by Region (2027-2032) Table 65. Beacon Pharma Company Information Table 66. Beacon Pharma Business Overview Table 67. Beacon Pharma Osimertinib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Beacon Pharma Osimertinib Product Portfolio Table 69. Beacon Pharma Recent Development Table 70. Drug International Company Information Table 71. Drug International Business Overview Table 72. Drug International Osimertinib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Drug International Osimertinib Product Portfolio Table 74. Drug International Recent Development Table 75. Everest Pharmaceuticals Company Information Table 76. Everest Pharmaceuticals Business Overview Table 77. Everest Pharmaceuticals Osimertinib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Everest Pharmaceuticals Osimertinib Product Portfolio Table 79. Everest Pharmaceuticals Recent Development Table 80. Incepta Pharmaceuticals Limited Company Information Table 81. Incepta Pharmaceuticals Limited Business Overview Table 82. Incepta Pharmaceuticals Limited Osimertinib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Incepta Pharmaceuticals Limited Osimertinib Product Portfolio Table 84. Incepta Pharmaceuticals Limited Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Osimertinib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AstraZeneca Osimertinib Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Osimertinib Distributors List Table 93. Osimertinib Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Osimertinib Product Image Figure 2. Global Osimertinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Osimertinib Sales (2021-2032) & (k pcs) Figure 5. Global Osimertinib Average Price (US$/pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Osimertinib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 80mg*30 Tablets Image Figure 9. 80mg*10 Tablets Image Figure 10. 40mg*30 Tablets Image Figure 11. 40mg*10 Tablets Image Figure 12. Global Osimertinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 13. Global Osimertinib Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Osimertinib Sales Market Share by Type (2021-2032) Figure 15. Global Osimertinib Revenue by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 16. Global Osimertinib Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Osimertinib Revenue Market Share by Type (2021-2032) Figure 18. Locally Advanced NSCLC Image Figure 19. Metastatic NSCLC Image Figure 20. Others Image Figure 21. Global Osimertinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Osimertinib Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Osimertinib Sales Market Share by Application (2021-2032) Figure 24. Global Osimertinib Revenue by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 25. Global Osimertinib Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Osimertinib Revenue Market Share by Application (2021-2032) Figure 27. North America Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 28. North America Osimertinib Sales Market Share by Country (2021-2032) Figure 29. U.S. Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 30. Canada Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 31. Mexico Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 32. Europe Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 33. Europe Osimertinib Sales Market Share by Country (2021-2032) Figure 34. Germany Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 35. France Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 36. U.K. Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 37. Italy Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 38. Netherlands Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 39. Asia Pacific Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 40. Asia Pacific Osimertinib Sales Market Share by Country (2021-2032) Figure 41. China Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 42. Japan Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 43. South Korea Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 44. Southeast Asia Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 45. India Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 46. Australia Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 47. South America, Middle East and Africa Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 48. South America, Middle East and Africa Osimertinib Sales Market Share by Country (2021-2032) Figure 49. Brazil Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 50. South Africa Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 51. Saudi Arabia Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 52. Turkey Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 53. Argentina Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 54. UAE Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 55. Egypt Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 56. Chile Osimertinib Sales and Growth Rate (2021-2032) & (k pcs) Figure 57. Global Osimertinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Osimertinib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Osimertinib Revenue (2021-2032) & (US$ Million) Figure 60. North America Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Osimertinib Revenue (2021-2032) & (US$ Million) Figure 62. Europe Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Osimertinib Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Osimertinib Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Osimertinib Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Osimertinib Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg*30 Tablets
  • 80mg*10 Tablets
  • 40mg*30 Tablets
  • 40mg*10 Tablets
Applications
  • Locally Advanced NSCLC
  • Metastatic NSCLC
  • Others
Companies covered
  • Beacon Pharma
  • Drug International
  • Everest Pharmaceuticals
  • Incepta Pharmaceuticals Limited
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Osimertinib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Osimertinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Osimertinib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Osimertinib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Osimertinib Market Dynamics
  1. 2.1 Osimertinib Industry Trends
  2. 2.2 Osimertinib Industry Drivers
  3. 2.3 Osimertinib Industry Opportunities and Challenges
  4. 2.4 Osimertinib Industry Restraints
3 Osimertinib Market by Manufacturers
  1. 3.1 Global Osimertinib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Osimertinib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Osimertinib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Osimertinib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Osimertinib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Osimertinib Manufacturers, Product Type & Application
  7. 3.7 Global Osimertinib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Osimertinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Osimertinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Osimertinib Tier 1, Tier 2, and Tier 3
4 Osimertinib Market by Type
  1. 4.1 Osimertinib Type Introduction
  2. 4.1.1 80mg*30 Tablets
  3. 4.1.2 80mg*10 Tablets
  4. 4.1.3 40mg*30 Tablets
  5. 4.1.4 40mg*10 Tablets
  6. 4.2 Global Osimertinib Sales by Type
  7. 4.2.1 Global Osimertinib Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Osimertinib Sales by Type (2021-2032)
  9. 4.2.3 Global Osimertinib Sales Market Share by Type (2021-2032)
  10. 4.3 Global Osimertinib Revenue by Type
  11. 4.3.1 Global Osimertinib Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Osimertinib Revenue by Type (2021-2032)
  13. 4.3.3 Global Osimertinib Revenue Market Share by Type (2021-2032)
5 Osimertinib Market by Application
  1. 5.1 Osimertinib Application Introduction
  2. 5.1.1 Locally Advanced NSCLC
  3. 5.1.2 Metastatic NSCLC
  4. 5.1.3 Others
  5. 5.2 Global Osimertinib Sales by Application
  6. 5.2.1 Global Osimertinib Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Osimertinib Sales by Application (2021-2032)
  8. 5.2.3 Global Osimertinib Sales Market Share by Application (2021-2032)
  9. 5.3 Global Osimertinib Revenue by Application
  10. 5.3.1 Global Osimertinib Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Osimertinib Revenue by Application (2021-2032)
  12. 5.3.3 Global Osimertinib Revenue Market Share by Application (2021-2032)
6 Global Osimertinib Sales by Region
  1. 6.1 Global Osimertinib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Osimertinib Sales by Region (2021-2032)
  3. 6.2.1 Global Osimertinib Sales by Region (2021-2026)
  4. 6.2.2 Global Osimertinib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Osimertinib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Osimertinib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Osimertinib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Osimertinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Osimertinib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Osimertinib Revenue by Region
  1. 7.1 Global Osimertinib Revenue by Region
  2. 7.1.1 Global Osimertinib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Osimertinib Revenue by Region (2021-2026)
  4. 7.1.3 Global Osimertinib Revenue by Region (2027-2032)
  5. 7.1.4 Global Osimertinib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Osimertinib Revenue (2021-2032)
  8. 7.2.2 North America Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Osimertinib Revenue (2021-2032)
  11. 7.3.2 Europe Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Osimertinib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Osimertinib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Osimertinib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Beacon Pharma
  2. 8.1.1 Beacon Pharma Company Information
  3. 8.1.2 Beacon Pharma Business Overview
  4. 8.1.3 Beacon Pharma Osimertinib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Beacon Pharma Osimertinib Product Portfolio
  6. 8.1.5 Beacon Pharma Recent Developments
  7. 8.2 Drug International
  8. 8.2.1 Drug International Company Information
  9. 8.2.2 Drug International Business Overview
  10. 8.2.3 Drug International Osimertinib Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Drug International Osimertinib Product Portfolio
  12. 8.2.5 Drug International Recent Developments
  13. 8.3 Everest Pharmaceuticals
  14. 8.3.1 Everest Pharmaceuticals Company Information
  15. 8.3.2 Everest Pharmaceuticals Business Overview
  16. 8.3.3 Everest Pharmaceuticals Osimertinib Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Everest Pharmaceuticals Osimertinib Product Portfolio
  18. 8.3.5 Everest Pharmaceuticals Recent Developments
  19. 8.4 Incepta Pharmaceuticals Limited
  20. 8.4.1 Incepta Pharmaceuticals Limited Company Information
  21. 8.4.2 Incepta Pharmaceuticals Limited Business Overview
  22. 8.4.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Incepta Pharmaceuticals Limited Osimertinib Product Portfolio
  24. 8.4.5 Incepta Pharmaceuticals Limited Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Osimertinib Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Osimertinib Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Osimertinib Value Chain Analysis
  2. 9.1.1 Osimertinib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Osimertinib Production Mode & Process
  6. 9.2 Osimertinib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Osimertinib Distributors
  9. 9.2.3 Osimertinib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst